antimony pentachloride has been researched along with meglumine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arboix, M; Carrió, J; de Colmenares, M; Gállego, M; Portús, M; Riera, C | 1 |
| de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP | 1 |
2 other study(ies) available for antimony pentachloride and meglumine
| Article | Year |
|---|---|
Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Culture Media; Dogs; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 2000 |
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Diseases; Kidney Function Tests; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2008 |